Basics Biodesix, Inc. Common Stock IPO Date: November 1, 2020 Sector: Healthcare Industry: Healthcare Providers & Services Market Cap: $50.77M Activated in VL: True Average Daily Range Avg Daily Range: $0.21 | 4.50% Avg Daily Range (30 D): $0.03 | 8.25% Avg Daily Range (90 D): $0.04 | 5.83% Institutional Daily Volume Avg Daily Volume: .52M Avg Daily Volume (30 D): 13.68M Avg Daily Volume (90 D): 4.88M Trade Size Avg Trade Size (Sh.): 405 Avg Trade Size (Sh.) (30 D): 892 Avg Trade Size (Sh.) (90 D): 803 Institutional Trades Total Inst.Trades: 35 Avg Inst. Trade: $1.84M Avg Inst. Trade (30 D): $.53M Avg Inst. Trade (90 D): $.76M Avg Inst. Trade Volume: .62M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.84M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 457.15K         News May 15, 2025 @ 10:00 AM Biodesix Announces New Clinical and Economic Data ... Source: N/A Apr 29, 2025 @ 10:00 AM Biodesix to Report First Quarter 2025 Financial Re... Source: N/A Apr 23, 2025 @ 10:00 AM Biodesix partner, Friends of Cancer Research, publ... Source: N/A Mar 3, 2025 @ 9:01 PM Biodesix Announces Fourth Quarter and Fiscal Year ... Source: N/A Feb 26, 2025 @ 11:00 AM Biodesix to Present at TD Cowen 45th Annual Health... Source: N/A Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.08 $-.08 $-.14 Diluted EPS $-.08 $-.08 $-.14 Revenue $ 17.96M $ 17.93M $ 14.82M Gross Profit $ $ $ Net Income / Loss $ -11.1M $ -10.81M $ -13.61M Operating Income / Loss $ -9.14M $ -8.24M $ -11.02M Cost of Revenue $ $ $ Net Cash Flow $ -8.64M $ 30.73M $ -14.79M PE Ratio